Radioimmunotherapy for treatment of acute myeloid leukemia
CA3329371A1Undetermined Publication Date: 2025-11-06RGT UNIV OF CALIFORNIA
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CA3329371
- Authority / Receiving Office
- CA · CA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-04-28
- Filing Date
- 2025-04-28
- Publication Date
- 2025-11-06
Abstract
Provided are radioimmunoconjugates comprising an antibody that specifically bind to the activated form of integrin β 2 ; a radionuclide which may be an alpha emitter or a beta emitter such as 225 Ac; and a chelator such as Macropa, and derivatives thereof, wherein the chelator chelates to radionuclide, and wherein the chelator is coupled to the antibody through a link comprising poly(ethylene glycol) moieties and methods of using the radioimmunoconjugates for treating cancer and for detecting cancer cells.
Need to check novelty before this filing date? Find Prior Art
